Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of Chromadex Corp (NASDAQ: CDXC) closed at $2.73 in the last session, up 3.02% from day before closing price of $2.65. In other words, the price has increased by $3.02 from its previous closing price. On the day, 6.31 million shares were traded. CDXC stock price reached its highest trading level at $2.8 during the session, while it also had its lowest trading level at $2.57.
Ratios:
We take a closer look at CDXC’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 7.48 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 46.45. For the most recent quarter (mrq), Quick Ratio is recorded 1.88 and its Current Ratio is at 2.52. In the meantime, Its Debt-to-Equity ratio is 0.11 whereas as Long-Term Debt/Eq ratio is at 0.08.
On August 11, 2022, B. Riley Securities Downgraded its rating to Neutral which previously was Buy and also lowered its target price recommendation from $6 to $2.40.
On March 08, 2022, ROTH Capital started tracking the stock assigning a Buy rating and target price of $7.ROTH Capital initiated its Buy rating on March 08, 2022, with a $7 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Dec 01 ’23 when Gerber Brianna bought 5,000 shares for $1.41 per share. The transaction valued at 7,050 led to the insider holds 27,436 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CDXC now has a Market Capitalization of 206220928 and an Enterprise Value of 182489792. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.48 while its Price-to-Book (P/B) ratio in mrq is 7.09. Its current Enterprise Value per Revenue stands at 2.194 whereas that against EBITDA is -53.879.
Stock Price History:
Over the past 52 weeks, CDXC has reached a high of $4.65, while it has fallen to a 52-week low of $1.25. The 50-Day Moving Average of the stock is -15.04%, while the 200-Day Moving Average is calculated to be 27.41%.
Shares Statistics:
According to the various share statistics, CDXC traded on average about 309.83K shares per day over the past 3-months and 928920 shares per day over the past 10 days. A total of 74.98M shares are outstanding, with a floating share count of 48.51M. Insiders hold about 35.79% of the company’s shares, while institutions hold 17.55% stake in the company. Shares short for CDXC as of 1718323200 were 1874958 with a Short Ratio of 6.05, compared to 1715731200 on 1696905. Therefore, it implies a Short% of Shares Outstanding of 1874958 and a Short% of Float of 3.8599998.
